Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Gut|January 29, 2011
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapyJean-François Rahier, Pavol Papay, Julia Salleron, et al.
European Journal of Gastroenterology & Hepatology|September 2, 2020
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohortClas-Göran Af Björkesten, Tuire Ilus, Taru Hallinen, et al.
Autoimmunity|April 28, 2022
Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseasesTea Lamberg, Taina Sipponen, Sanna Valtanen, et al.
NEJM Evidence|February 6, 2024
Discontinuation of Infliximab Therapy in Patients with Crohn's DiseaseSine Buhl, Casper Steenholdt, Jørn Brynskov, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 14, 2019
Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practiceTero Ylisaukko-Oja, Saku Torvinen, Jaakko Aaltonen, et al.
Scandinavian Journal of Gastroenterology|December 21, 2017
High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)Tero Ylisaukko-Oja, Jaakko Aaltonen, Heikki Nuutinen, et al.
Inflammatory Bowel Diseases|May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European StudyUri Kopylov, Bram Verstockt, Luc Biedermann, et al.
Pageof 7